<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38130117</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1326-5377</ISSN><JournalIssue CitedMedium="Internet"><Volume>220</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>The Medical journal of Australia</Title><ISOAbbreviation>Med J Aust</ISOAbbreviation></Journal><ArticleTitle>The Alfred Health post-COVID-19 service, Melbourne, 2020-2022: an observational cohort study.</ArticleTitle><Pagination><StartPage>91</StartPage><EndPage>96</EndPage><MedlinePgn>91-96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5694/mja2.52192</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To determine the uptake of the Alfred Health Post-COVID service among people hospitalised with coronavirus disease 2019 (COVID-19) or referred by general practitioners; to describe their characteristics and symptoms at eight weeks and the clinical services they required.</AbstractText><AbstractText Label="STUDY DESIGN">Observational cohort study.</AbstractText><AbstractText Label="SETTING">Outpatient post-COVID-19 follow-up service in a tertiary Melbourne hospital.</AbstractText><AbstractText Label="PARTICIPANTS">All people admitted to Alfred Health (inpatients, hospital-in-the-home) with COVID-19, 19 March 2020 - 28 December 2022; people with persistent symptoms referred by general practitioners in the Alfred Health catchment area during 2022.</AbstractText><AbstractText Label="INTERVENTION">Questionnaire-based symptom assessment eight weeks after onset of COVID-19. Dyspnoea, fatigue, depression, anxiety, and post-traumatic stress disorder were assessed with standardised tools, as were health status and health-related quality of life; return to work or study, weight loss, and altered cognition and memory were also assessed. Screening was followed by physical assessment and management at the service (specialist general medicine review, physiotherapist, allied health assistant, neuropsychologist) and referral to other specialist medical services as required.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Proportion of eligible people who used the service for follow-up at eight weeks; proportions of service users who reported symptoms and return to pre-COVID-19 employment or study; clinical services required by service users.</AbstractText><AbstractText Label="RESULTS">Of 6712 people invited for screening, 726 completed questionnaires (11%). At least one persistent symptom was reported by 385 of 642 respondents (60% of respondents, 5.7% of invitees), most frequently memory (371 of 656, 57%) or concentration problems (431 of 656, 66%), dyspnoea (197 of 703, 28%), and extreme fatigue (189 of 673, 28%). Sixty-seven of 453 respondents had not returned to pre-COVID-19 work or study (15%). People were referred to a variety of medical and non-medical services for management, including specialist medical clinics, allied health, and rehabilitation. Among 71 people who also completed questionnaires at twelve months, the proportions who reported fatigue, anxiety, and memory and concentration changes were similar at both assessments.</AbstractText><AbstractText Label="CONCLUSIONS">After acute COVID-19 that required hospital admission or was followed by persistent symptoms in community care, a small proportion of people (5.7%) reported symptoms that required medical and allied health specialist assessment and management. Our findings may assist planning services for people with long COVID.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Medical Journal of Australia published by John Wiley &amp; Sons Australia, Ltd on behalf of AMPCo Pty Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holland</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, VIC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fineberg</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marceau</LastName><ForeName>Tunya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaman</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchanan</LastName><ForeName>Jo-Anne</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uren</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dal Corso</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lannin</LastName><ForeName>Natasha A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mellerick</LastName><ForeName>Christie R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernando</LastName><ForeName>Kathya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, VIC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bondarenko</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, VIC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alfred Health, Melbourne, VIC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Med J Aust</MedlineTA><NlmUniqueID>0400714</NlmUniqueID><ISSNLinking>0025-729X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Med J Aust. 2024 Aug 19;221(4):226. doi: 10.5694/mja2.52379</RefSource><PMID Version="1">38965713</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Med J Aust. 2024 Aug 19;221(4):226. doi: 10.5694/mja2.52377</RefSource><PMID Version="1">39004691</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Health services research</Keyword><Keyword MajorTopicYN="N">Referral and consultation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38130117</ArticleId><ArticleId IdType="doi">10.5694/mja2.52192</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et&#xa0;al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun 2022; 13: 3528.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et&#xa0;al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11: 16144.</Citation></Reference><Reference><Citation>Evans R, McAuley H, Harrison E; PHOSP-COVID Collaborative Group. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP- COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2022; 10: 1275-1279.</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. 6 Oct 2021. https://apps.who.int/iris/handle/10665/345824 (viewed Apr 2023).</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE); Scottish Intercollegiate Guidelines Network (SIGN); Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the long-term effects of COVID-19 [NG188]. Updated 11 Nov 2021. https://www.nice.org.uk/guidance/ng188 (viewed Apr 2023).</Citation></Reference><Reference><Citation>Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580-586.</Citation></Reference><Reference><Citation>Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res 2003; 54: 345-352.</Citation></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.</Citation></Reference><Reference><Citation>Christianson S, Marren J. The Impact of Event Scale - revised (IES-R). Medsurg Nurs 2012; 21: 321-322.</Citation></Reference><Reference><Citation>EuroQol Research Foundation. EQ-5D-5L user guide version 3.0. Basic information on how to use the EQ-5D-5L instrument. Sept 2019. https://euroqol.org/publications/user-guides (viewed Apr 2023).</Citation></Reference><Reference><Citation>World Health Organization (Europe). Support for rehabilitation: self-management after COVID-19 related illness. 25 June 2020. https://www.who.int/publications/m/item/support-for-rehabilitation-self-management-after-covid-19-related-illness (viewed Apr 2023).</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133-146.</Citation></Reference><Reference><Citation>Bell ML, Catalfamo CJ, Farland LV, et&#xa0;al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One 2021; 16: e0254347.</Citation></Reference><Reference><Citation>World Health Organization. Mental health and COVID-19: early evidence of the pandemic's impact. Scientific brief, 2 March 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1 (viewed Nov 2023).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>